Tekla Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Tekla Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-55,717	Closed	-$4.2M	–	175
2015 Q2	$4.2M	Hold	55,717	–	–	0.15%	90
2015 Q1	$2.79M	Sell	55,717 -55,716	-50%	-$2.34M	0.11%	97
2014 Q4	$3.86M	Hold	111,433	–	–	0.18%	75
2014 Q3	$3.65M	Buy	111,433 +62,433	+127%	+$2.2M	0.17%	96
2014 Q2	$1.88M	Buy	+49,000	New	+$1.71M	0.17%	58

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Tekla Capital Management's KYTH Position: Q3 2015 in Review

Tekla Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 55,717 shares — an estimated $4.2M sold.

Tekla Capital Management first reported a position in KYTH in Q2 2014 and held it in 5 quarters. The position peaked at $4.2M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Tekla Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Tekla Capital Management sold 55,717 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $4.2M.
Tekla Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 5 quarters.
Tekla Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $4.2M in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Tekla Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.